1. Home
  2. RAPP vs ABVX Comparison

RAPP vs ABVX Comparison

Compare RAPP & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPP
  • ABVX
  • Stock Information
  • Founded
  • RAPP 2022
  • ABVX 2013
  • Country
  • RAPP United States
  • ABVX France
  • Employees
  • RAPP N/A
  • ABVX N/A
  • Industry
  • RAPP
  • ABVX
  • Sector
  • RAPP
  • ABVX
  • Exchange
  • RAPP Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • RAPP 844.6M
  • ABVX 722.3M
  • IPO Year
  • RAPP 2024
  • ABVX N/A
  • Fundamental
  • Price
  • RAPP $18.46
  • ABVX $7.60
  • Analyst Decision
  • RAPP Strong Buy
  • ABVX Strong Buy
  • Analyst Count
  • RAPP 4
  • ABVX 6
  • Target Price
  • RAPP $37.33
  • ABVX $38.67
  • AVG Volume (30 Days)
  • RAPP 136.9K
  • ABVX 142.2K
  • Earning Date
  • RAPP 02-10-2025
  • ABVX 09-09-2024
  • Dividend Yield
  • RAPP N/A
  • ABVX N/A
  • EPS Growth
  • RAPP N/A
  • ABVX N/A
  • EPS
  • RAPP N/A
  • ABVX N/A
  • Revenue
  • RAPP N/A
  • ABVX $9,676,417.00
  • Revenue This Year
  • RAPP N/A
  • ABVX $31.67
  • Revenue Next Year
  • RAPP N/A
  • ABVX $1,189.66
  • P/E Ratio
  • RAPP N/A
  • ABVX N/A
  • Revenue Growth
  • RAPP N/A
  • ABVX 100.87
  • 52 Week Low
  • RAPP $16.55
  • ABVX $7.00
  • 52 Week High
  • RAPP $29.74
  • ABVX $17.02
  • Technical
  • Relative Strength Index (RSI)
  • RAPP N/A
  • ABVX 38.69
  • Support Level
  • RAPP N/A
  • ABVX $7.00
  • Resistance Level
  • RAPP N/A
  • ABVX $8.18
  • Average True Range (ATR)
  • RAPP 0.00
  • ABVX 0.49
  • MACD
  • RAPP 0.00
  • ABVX 0.01
  • Stochastic Oscillator
  • RAPP 0.00
  • ABVX 32.43

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

Share on Social Networks: